Related references
Note: Only part of the references are listed.The Role of Tumor Microenvironment in Multiple Myeloma Development and Progression
Almudena Garcia-Ortiz et al.
CANCERS (2021)
The Lipoprotein Transport System in the Pathogenesis of Multiple Myeloma: Advances and Challenges
Vasileios Lazaris et al.
FRONTIERS IN ONCOLOGY (2021)
The exosomal integrin α5β1/AEP complex derived from epithelial ovarian cancer cells promotes peritoneal metastasis through regulating mesothelial cell proliferation and migration
Xiaoduan Li et al.
CELLULAR ONCOLOGY (2020)
Multiple Myeloma Incidence and Mortality Around the Globe; Interrelations Between Health Access and Quality, Economic Resources, and Patient Empowerment
Heinz Ludwig et al.
ONCOLOGIST (2020)
Hypoxia-inducible hexokinase-2 enhances anti-apoptotic function via activating autophagy in multiple myeloma
Sho Ikeda et al.
CANCER SCIENCE (2020)
High Plasma Levels of Legumain in Patients with Complex Coronary Lesions
Tomohiko C. Umei et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2020)
Influence of metformin on HIF-1 pathway in multiple myeloma
Kinga A. Kocemba-Pilarczyk et al.
PHARMACOLOGICAL REPORTS (2020)
Cholesterol Levels Provide Prognostic Information in Patients with Multiple Myeloma
Xu Liu et al.
CLINICAL LABORATORY (2020)
KDM5 demethylases and their role in cancer cell chemoresistance
Johana Plch et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Metabolic, Anti-apoptotic and Immune Evasion Strategies of Primary Human Myeloma Cells Indicate Adaptations to Hypoxia
Lukas Janker et al.
MOLECULAR & CELLULAR PROTEOMICS (2019)
Recent advances in the development of legumain-selective chemical probes and peptide prodrugs
Marcin Poreba
BIOLOGICAL CHEMISTRY (2019)
Biology and therapy of multiple myeloma
Douglas E. Joshua et al.
MEDICAL JOURNAL OF AUSTRALIA (2019)
Mubritinib Targets the Electron Transport Chain Complex I and Reveals the Landscape of OXPHOS Dependency in Acute Myeloid Leukemia
Irene Baccelli et al.
CANCER CELL (2019)
The impact of the bone marrow microenvironment on multiple myeloma
Jianhao Hou et al.
ONCOLOGY REPORTS (2019)
The PRIDE database and related tools and resources in 2019: improving support for quantification data
Yasset Perez-Riverol et al.
NUCLEIC ACIDS RESEARCH (2019)
Hypoxia-Modified Cancer Cell Metabolism
Wafaa Al Tameemi et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)
Comprehensive characterization of the mutational landscape in multiple myeloma cell lines reveals potential drivers and pathways associated with tumor progression and drug resistance
Veronika Vikova et al.
THERANOSTICS (2019)
Identification of High Serum Apolipoprotein A1 as a Favorable Prognostic Indicator in Patients with Multiple Myeloma
Lifan Liang et al.
JOURNAL OF CANCER (2019)
Hypoxia-induced upregulation of BMX kinase mediates therapeutic resistance in acute myeloid leukemia
Jolieke G. van Oosterwijk et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Targeting the hypoxia pathway in malignant plasma cells by using 17-allylamino-17-demethoxygeldanamycin
Kinga A. Kocemba-Pilarczyk et al.
ACTA BIOCHIMICA POLONICA (2018)
Multiple myeloma cells adapted to long-exposure of hypoxia exhibit stem cell characters with TGF-β/Smad pathway activation
Yoko Nakagawa et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Whole exome sequencing identifies novel mutations of epigenetic regulators in chemorefractory pediatric acute myeloid leukemia
Di Zhan et al.
LEUKEMIA RESEARCH (2018)
Integrated Analysis of Long Non-Coding RNA and mRNA Expression Profile in Pancreatic Cancer Derived Exosomes Treated Dendritic Cells by Microarray Analysis
Jionghuang Chen et al.
JOURNAL OF CANCER (2018)
Global Burden of Multiple Myeloma ASystematic Analysis for the Global Burden of Disease Study 2016
Andrew J. Cowan et al.
JAMA ONCOLOGY (2018)
Exosomes play a role in multiple myeloma bone disease and tumor development by targeting osteoclasts and osteoblasts
Sylvia Faict et al.
BLOOD CANCER JOURNAL (2018)
Hypoxia-inducible KDM3A addiction in multiple myeloma
Sho Ikeda et al.
BLOOD ADVANCES (2018)
PKM2 and other key regulators of Warburg effect positively correlate with CD147 (EMMPRIN) gene expression and predict survival in multiple myeloma
S. Panchabhai et al.
LEUKEMIA (2017)
NEK2 Promotes Aerobic Glycolysis in Multiple Myeloma Through Regulating Splicing of Pyruvate Kinase
Zhimin Gu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Therapy for Relapsed Multiple Myeloma: Guidelines From the Mayo Stratification for Myeloma and Risk-Adapted Therapy
David Dingli et al.
MAYO CLINIC PROCEEDINGS (2017)
Legumain Regulates Differentiation Fate of Human Bone Marrow Stromal Cells and Is Altered in Postmenopausal Osteoporosis
Abbas Jafari et al.
STEM CELL REPORTS (2017)
Long non-coding RNA MALAT1 is an inducible stress response gene associated with extramedullary spread and poor prognosis of multiple myeloma
Hiroshi Handa et al.
BRITISH JOURNAL OF HAEMATOLOGY (2017)
A phase 1b study of isatuximab plus lenalidomide and dexamethasone for relapsed/refractory multiple myeloma
Thomas Martin et al.
BLOOD (2017)
Hypoxia-inducible microRNA-210 regulates the DIMT1-IRF4 oncogenic axis in multiple myeloma
Sho Ikeda et al.
CANCER SCIENCE (2017)
Structure and function of legumain in health and disease
Elfriede Dall et al.
BIOCHIMIE (2016)
Microenvironmental oxygen partial pressure in acute myeloid leukemia: Is there really a role for hypoxia?
Christina T. Rieger et al.
EXPERIMENTAL HEMATOLOGY (2016)
Statins Are Associated With Reduced Mortality in Multiple Myeloma
Kristen Marie Sanfilippo et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
The Perseus computational platform for comprehensive analysis of (prote)omics data
Stefka Tyanova et al.
NATURE METHODS (2016)
Hypoxia and metabolic adaptation of cancer cells
K. L. Eales et al.
ONCOGENESIS (2016)
Development of a potent and selective cell penetrant Legumain inhibitor
Kerry A. Ness et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
Metabolic Signature Identifies Novel Targets for Drug Resistance in Multiple Myeloma
Patricia Maiso et al.
CANCER RESEARCH (2015)
Enhancing Hematopoietic Stem Cell Transplantation Efficacy by Mitigating Oxygen Shock
Charlie R. Mantel et al.
CELL (2015)
High expression of the cysteine proteinase legumain in colorectal cancer - Implications for therapeutic targeting
Mads H. Haugen et al.
EUROPEAN JOURNAL OF CANCER (2015)
Pyruvate kinase isoform M2 (PKM2) participates in multiple myeloma cell proliferation, adhesion and chemoresistance
Yunhua He et al.
LEUKEMIA RESEARCH (2015)
Therapeutic targeting of hypoxia and hypoxia-inducible factor 1 alpha in multiple myeloma
Enrica Borsi et al.
TRANSLATIONAL RESEARCH (2015)
Hypoxia induces a lipogenic cancer cell phenotype via HIF1α-dependent and -independent pathways
Alessandro Valli et al.
ONCOTARGET (2015)
Clinicopathologic significance of legumain overexpression in cancer: a systematic review and meta-analysis
Ye Zhen et al.
SCIENTIFIC REPORTS (2015)
Targeting the bone marrow microenvironment in multiple myeloma
Yawara Kawano et al.
IMMUNOLOGICAL REVIEWS (2015)
Inactivation of Tristetraprolin in Chronic Hypoxia Provokes the Expression of Cathepsin B
Dominik C. Fuhrmann et al.
MOLECULAR AND CELLULAR BIOLOGY (2015)
The histone demethylase enzyme KDM3A is a key estrogen receptor regulator in breast cancer
Mark A. Wade et al.
NUCLEIC ACIDS RESEARCH (2015)
KDM5C Is Overexpressed in Prostate Cancer and Is a Prognostic Marker for Prostate-Specific Antigen-Relapse Following Radical Prostatectomy
Johannes Stein et al.
AMERICAN JOURNAL OF PATHOLOGY (2014)
Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1
Tomohiro Umezu et al.
BLOOD (2014)
MALAT1 long non-coding RNA is overexpressed in multiple myeloma and may serve as a marker to predict disease progression
Shih-Feng Cho et al.
BMC CANCER (2014)
Direct measurement of local oxygen concentration in the bone marrow of live animals
Joel A. Spencer et al.
NATURE (2014)
Improved vectors and genome-wide libraries for CRISPR screening
Neville E. Sanjana et al.
NATURE METHODS (2014)
Hypoxia promotes stem cell-like phenotype in multiple myeloma cells
B. Muz et al.
BLOOD CANCER JOURNAL (2014)
Hypoxia inducible factor-1 alpha as a therapeutic target in multiple myeloma
Enrica Borsi et al.
ONCOTARGET (2014)
Chronic hypoxia alters mitochondrial composition in human macrophages
Dominik Christian Fuhrmann et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2013)
Hypoxia reduces CD138 expression and induces an immature and stem cell-like transcriptional program in myeloma cells
Yawara Kawano et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
Hypoxia-inducible factor (HIF)-1α suppression in myeloma cells blocks tumoral growth in vivo inhibiting angiogenesis and bone destruction
P. Storti et al.
LEUKEMIA (2013)
Quantitative imaging of haematopoietic stem and progenitor cell localization and hypoxic status in the bone marrow microenvironment
Cesar Nombela-Arrieta et al.
NATURE CELL BIOLOGY (2013)
Low-density lipoprotein cholesterol suppresses apoptosis in human multiple myeloma cells
Jose Manuel Tirado-Velez et al.
ANNALS OF HEMATOLOGY (2012)
Hypoxia-inducible factor-1 (HIF-1) promotes LDL and VLDL uptake through inducing VLDLR under hypoxia
Guo-Min Shen et al.
BIOCHEMICAL JOURNAL (2012)
Hypoxia promotes dissemination of multiple myeloma through acquisition of epithelial to mesenchymal transition-like features
Abdel Kareem Azab et al.
BLOOD (2012)
Bone Marrow Microenvironment in Multiple Myeloma Progression
S. Manier et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2012)
Aberrant global methylation patterns affect the molecular pathogenesis and prognosis of multiple myeloma
Brian A. Walker et al.
BLOOD (2011)
Metabolic Regulation of Hematopoietic Stem Cells in the Hypoxic Niche
Toshio Suda et al.
CELL STEM CELL (2011)
Andromeda: A Peptide Search Engine Integrated into the MaxQuant Environment
Juergen Cox et al.
JOURNAL OF PROTEOME RESEARCH (2011)
Adaptation to Survival in Germinal Center Is the Initial Step in Onset of Indolent Stage of Multiple Myeloma
Ariosto S. Silva et al.
MOLECULAR PHARMACEUTICS (2011)
Jumonji Domain Containing 1A Is a Novel Prognostic Marker for Colorectal Cancer: In vivo Identification from Hypoxic Tumor Cells
Mamoru Uemura et al.
CLINICAL CANCER RESEARCH (2010)
Hypoxia-inducible factor-2 is a novel regulator of aberrant CXCL12 expression in multiple myeloma plasma cells
Sally K. Martin et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Low bone marrow oxygen tension and hypoxia-inducible factor-1α overexpression characterize patients with multiple myeloma: role on the transcriptional and proangiogenic profiles of CD138+ cells
S. Colla et al.
LEUKEMIA (2010)
Genome-wide identification of hypoxia-inducible factor binding sites and target genes by a probabilistic model integrating transcription-profiling data and in silico binding site prediction
Amaya Ortiz-Barahona et al.
NUCLEIC ACIDS RESEARCH (2010)
Inhibition of hypoxia-inducible factor-1 function enhances the sensitivity of multiple myeloma cells to melphalan
Yongzhen Hu et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Integrative analysis of HIF binding and transactivation reveals its role in maintaining histone methylation homeostasis
Xiaobo Xia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Heather R. Christofk et al.
NATURE (2008)
A One Pot, One Step, Precision Cloning Method with High Throughput Capability
Carola Engler et al.
PLOS ONE (2008)
Cholesterol levels in patients with multiple myeloma
Irfan Yavasoglu et al.
ANNALS OF HEMATOLOGY (2008)
Hypoxia, HIF1 and glucose metabolism in the solid tumour
Nicholas C. Denko
NATURE REVIEWS CANCER (2008)
JHDM2A, a JmjC-containing H3K9 dernethylase, facilitates transcription activation by androgen receptor
Kenichi Yamane et al.
CELL (2006)
Production and purification of lentiviral vectors
Gustavo Tiscornia et al.
NATURE PROTOCOLS (2006)
The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma
E Tian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Endothelial cells in the bone marrow of patients with multiple myeloma
A Vacca et al.
BLOOD (2003)
Comparison of gene expression profiling between malignant and normal plasma cells with oligonucleotide arrays
J De Vos et al.
ONCOGENE (2002)
High-level transduction and gene expression in hematopoietic repopulating cells using a human imunodeficiency virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter
C Demaison et al.
HUMAN GENE THERAPY (2002)
Share Paper
